Author

Suman K. Shaw

Observed names: Shaw, Suman, Suman Shaw

Institution: Nirma University

Observed institution: Nirma University

ORCID: 0000-0001-9197-7615

Observed ORCID: 0000-0001-9197-7615

OpenAlex ID: A5040981245

Tetrahydroquinoline: An Efficient Scaffold As mTOR Inhibitor for the Treatment of Lung Cancer

2022 · Udit Chaube, Rajdeep Dey, et al. · Future Medicinal Chemistry · 23

Synthesis, biological screening, and binding mode analysis of some N-substituted tetrahydroquinoline analogs as apoptosis inducers and anticancer agents

2024 · Rajdeep Dey, Suman Shaw, et al. · Journal of Molecular Structure · 15

Designing of target‐specific N ‐substituted tetrahydroquinoline derivatives as potent mTOR inhibitors via integrated structure‐guided computational approaches

2024 · Suman Shaw, Rajdeep Dey, et al. · ChemistrySelect · 11

Exploring Tetrahydroquinoline Derivatives: A New Frontier in Cancer Treatment

2025 · Suman K. Shaw, Rajdeep Dey, et al. · Synlett · 5

Morpholine-Substituted Tetrahydroquinoline Derivatives as Potential mTOR Inhibitors: Synthesis, Computational Insights, and Cellular Analysis

2025 · Rajdeep Dey, Suman Shaw, et al. · Cancers · 5

Advancements in mTOR Inhibitors for Non-Small-Cell Lung Cancer: Mechanisms, Efficacy, and Future Perspectives

2024 · Aanal Thaker, Shrusti Patel, et al. · Synlett · 4

In Search of PI3K Inhibitors as Anticancer Agents: Molecular Modelling Through Virtual Screening, ADMET, and Molecular Dynamics Simulations

2025 · Suman Shaw, Rajdeep Dey, et al. · ChemistrySelect · 1

Expanding the Horizon of Pteridine Chemistry: Optimized Synthesis by the Isay Reaction, and Molecular-Docking Studies

2025 · Hardik G. Bhatt, Suman K. Shaw, et al. · Synlett · 1

The retroactive and future potentials of Aurora kinases in the treatment of cancer

2022 · Hardik Bhatt, Keerti Vishwakarma, et al. · Elsevier eBooks

2022 · Bekhzod Abdullaev, Mohammad Afzal, et al. · Elsevier eBooks

Works count: 11

Citation count: 65

H-index: 5

I10-index: 3